Medical News

RSS

Nuvo Research commences enrollment in WF10 Phase 2 clinical trial for allergic rhinitis

Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.

16 Mar 2010

Positive results from Phase IIa epilepsy study of ICA-105665

Icagen, Inc. today reported positive results in its Phase IIa epilepsy study of ICA-105665, the Company's novel orally available small molecule KCNQ potassium channel agonist.

16 Mar 2010

F1000 adds new Otolaryngology section to support extensive medicine coverage

Faculty of 1000 Biology, the award-winning literature awareness service for the life sciences, has launched the much anticipated Otolaryngology Faculty.

16 Mar 2010

Obama's legacy and democrats' electoral fates tied to overhaul, observers speculate

If Democrats fail to pass health legislation, the loss could have lasting consequences for a president whose supporters have become accustomed to victory, Time writes. "If the President fails to win the upcoming series of congressional votes designed to get health care legislation to his desk, it will be a calamitous failure for his presidency and for him personally, dwarfing the potholes he has hit during his first bumpy year in office.

16 Mar 2010

Aegis Health Group releases PRISM software to help hospital leaders improve physician relationships

Aegis Health Group, the nation's leading healthcare business development company, announces new software to help hospital leaders improve physician relationships, track referral patterns, better manage physician issues, and gain market intelligence. PRISM™, Aegis' proprietary physician relationship management software, is a browser-based database and contact-management program that can be customized to fit the unique needs of each hospital.

16 Mar 2010

FDA approves Watson Pharmaceuticals' ANDA for generic Cardizem LA

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.

16 Mar 2010

Major Catholic health group support Democrats' health reform

Catholic World: ''Breaking with the United States Conference of Catholic Bishops, the president of the Catholic Health Association has endorsed the Senate health care reform legislation that is scheduled to be voted on by the House of Representatives this week."

16 Mar 2010

Research reveals molecular mechanism of DNA repair

New research led by scientists at the University of Essex has given an insight into how the body finds damage in the DNA code to repair it.

16 Mar 2010

GOP criticizes House Dems likely 'self-executing rule' for health reform consideration

"House Republicans say they cannot block a Democratic maneuver that would allow Members to avoid a separate vote on the Senate health care bill. 'There is nothing that can prevent it,' said Rep. David Dreier (R-Calif.), the ranking member of the Rules Committee."

16 Mar 2010

Lilly receives exclusive rights to commercialize Acrux's testosterone solution

Eli Lilly and Company and Acrux announced today that they have entered into an exclusive worldwide license agreement for the potential commercialization of Acrux's experimental underarm testosterone solution (proposed tradename AXIRON™).

16 Mar 2010

Youngsters create short films to address obesity and eating disorders

Youth homelessness and eating disorders are two areas of health highlighted by young people in Cardiff in a project that uses digital technology to create short films which detail public health issues.

16 Mar 2010

Health care sparks battles between state, federal legislation

USA Today: "In a backlash against President Obama's health care legislation that stretches from Virginia to California, lawmakers in more than two-thirds of the states are scrambling to undercut the bill before it even passes Congress." Legal scholars say that state legislation isn't the final word, however. "The state measures are likely to be challenged in court, setting up new legal battles over whether federal law can trump state laws.

15 Mar 2010

Impax Laboratories initiates challenge of patent over generic TRILIPIX

Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patent listed by Abbott Laboratories and Fournier Laboratories Ireland Ltd. in connection with its TRILIPIX® (choline fenofibrate) delayed-release capsules, 135 mg and 45 mg.

15 Mar 2010

Issues over abortion, reconciliation rules remain in the path of health reform vote

A host of political challenges and possible pitfalls awaits lawmakers as they push toward a final vote on health reform -- among them, abortion, reconciliation rules and immigration.

15 Mar 2010

Gardasil vaccine: Two complaints filed in Washington Federal Claims court

Anapol Schwartz attorneys Lawrence Cohan and Melissa Fry Hague recently filed two Gardasil vaccine complaints – one on behalf of a Kensington, Calif., family, whose 15-year old daughter died after suffering from severe adverse reactions, and another on behalf of a 19-year old Lapeer, Mich., woman, who has a chronic, autoimmune disorder. The cases, filed in The Court of Federal Claims in Washington, D.C., seek recovery under the National Vaccine Injury Compensation Program.

15 Mar 2010

Experts discuss PEPFAR funding in congressional hearing

At a recent hearing of the House Subcommittee on Africa and Global Health, "[i]nternational health organisations working to help check the spread of AIDS in Africa said meagre increases in funds from the U.S. government this year would be a step backwards. Some experts also emphasised that prevention must get appropriate attention in any fight against the disease," Inter Press Service reports.

15 Mar 2010

TCAD therapy superior to double combinations and monotherapy against influenza viruses

Adamas Pharmaceuticals, Inc., a privately held company, announced today results from in vivo animal studies and in vitro tests demonstrating that its triple combination antiviral drug (TCAD) therapy is superior relative to double combinations and monotherapy against multiple strains of pandemic and avian influenza viruses. Results of these studies were presented Sunday evening in an oral session at the XII International Symposium on Respiratory Viral Infections being held in Taipei.

15 Mar 2010

Unlicensed software usage: iCan Benefit pays BSA $61,500 to settle claims

The Business Software Alliance (BSA), the voice of the world's commercial software industry, today announced a settlement with iCan Benefit Group of Boca Raton, FL. iCan Benefit paid $61,500 to BSA to settle claims that it had unlicensed copies of Adobe, Microsoft and Symantec software installed on its computers. As part of the settlement agreement, the company agreed to delete all unlicensed copies of software from its computers, acquire any licenses necessary to become compliant, and commit to implementing stronger software asset management (SAM) practices.

15 Mar 2010

Economists, Dems differ on who's to blame for insurers' rate hikes

Democrats assailed health insurers for hiking rates in recent weeks to gain popular momentum for their health overhaul, but health economists say insurers did cause high health costs, the Milwaukee Journal Sentinel reports. The economists "contend that insurance companies, while often meriting criticism for their practices, aren't to blame for high health care costs."

15 Mar 2010

Vertebroplasty: Patient selection vital

Patient selection is key for vertebroplasty—a minimally invasive treatment performed by interventional radiologists in individuals with painful osteoporotic vertebral compression fractures that fail to respond to conventional medical therapy—to be effective and successful, according to a study of more than 1,500 persons who were followed over seven years. Additionally, collaboration between an interventional radiologist and other medical experts in treating a patient is imperative, say researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

15 Mar 2010